Awarded
Suministro de Remsima® (Inflximab) para la continuación de los tratamientos actuales, excluyendo los nuevos tratamientos
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- KERN PHARMA, S.L.
- Contract value
- €286,088
- Bids received
- 1
- Published
- 9 Jan 2026
- Awarded
- 8 Jan 2026
- Contract start
- 9 Jan 2026
- Contract end
- 8 Jan 2030stated
- Region
- Araba/Álava